PortfoliosLab logoPortfoliosLab logo
Hyperfine, Inc. (HYPR)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US44916K1060
CUSIP
44916K106
IPO Date
Jan 27, 2021

Highlights

Market Cap
$101.74M
Enterprise Value
$66.66M
EPS (TTM)
-$0.42
Total Revenue (TTM)
$13.56M
Gross Profit (TTM)
$6.75M
EBITDA (TTM)
-$38.01M
Year Range
$0.53 - $2.22
Target Price
$1.60
ROA (TTM)
-64.37%
ROE (TTM)
-86.76%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Hyperfine, Inc.

Often compared with HYPR:
HYPR vs. QQQ

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Hyperfine, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Hyperfine, Inc. (HYPR) has returned 10.28% so far this year and 50.77% over the past 12 months.


Hyperfine, Inc.

1D
4.85%
1M
0.93%
YTD
10.28%
6M
-25.52%
1Y
50.77%
3Y*
-9.14%
5Y*
-35.90%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 27, 2021, HYPR's average daily return is 0.00%, while the average monthly return is -1.42%.

Historically, 46% of months were positive and 54% were negative. The best month was Feb 2023 with a return of +67.3%, while the worst month was Jul 2022 at -45.7%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, HYPR closed higher 44% of trading days. The best single day was Dec 12, 2022 with a return of +53.8%, while the worst single day was Oct 16, 2025 at -35.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202614.37%-4.46%0.93%10.28%
202525.00%-11.82%-26.15%1.21%-16.90%19.44%47.30%16.98%16.94%-22.76%-4.46%-8.48%11.28%
2024-4.46%7.48%-13.04%-19.00%3.21%1.67%37.65%-13.68%6.93%-9.39%3.21%-12.87%-21.43%
202314.60%67.26%-10.56%-2.08%16.31%31.10%35.35%-29.21%-0.49%-39.02%2.40%-12.50%33.33%
2022-39.59%-17.81%-1.67%-2.26%-16.47%-22.84%-45.74%10.74%-39.55%12.35%-12.09%5.00%-88.41%
20210.90%2.57%-3.47%-0.00%-1.20%-0.30%0.41%0.20%-0.10%0.81%0.00%-27.35%-27.57%

Benchmark Metrics

Hyperfine, Inc. has an annualized alpha of -14.19%, beta of 1.25, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since January 28, 2021.

  • This stock participated in 204.85% of S&P 500 Index downside but only 25.14% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-14.19%
Beta
1.25
0.05
Upside Capture
25.14%
Downside Capture
204.85%

Return for Risk

Risk / Return Rank

HYPR ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HYPR Risk / Return Rank: 6161
Overall Rank
HYPR Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
HYPR Sortino Ratio Rank: 6868
Sortino Ratio Rank
HYPR Omega Ratio Rank: 6565
Omega Ratio Rank
HYPR Calmar Ratio Rank: 6060
Calmar Ratio Rank
HYPR Martin Ratio Rank: 5656
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Hyperfine, Inc. (HYPR) and compare them to a chosen benchmark (S&P 500 Index).


HYPRBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.48

0.90

-0.41

Sortino ratio

Return per unit of downside risk

1.52

1.39

+0.14

Omega ratio

Gain probability vs. loss probability

1.19

1.21

-0.02

Calmar ratio

Return relative to maximum drawdown

0.85

1.40

-0.55

Martin ratio

Return relative to average drawdown

1.45

6.61

-5.16

Explore HYPR risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Hyperfine, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Hyperfine, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hyperfine, Inc. was 95.01%, occurring on May 23, 2025. The portfolio has not yet recovered.

The current Hyperfine, Inc. drawdown is 90.11%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.01%Dec 23, 2021857May 23, 2025
-10.54%Feb 17, 202189Jun 23, 2021127Dec 22, 2021216
-0.88%Jan 29, 20211Jan 29, 20212Feb 2, 20213
-0.83%Feb 11, 20211Feb 11, 20212Feb 16, 20213
-0.29%Feb 8, 20211Feb 8, 20211Feb 9, 20212

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hyperfine, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Hyperfine, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HYPR relative to other companies in the Medical Devices industry. Currently, HYPR has a P/S ratio of 6.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HYPR in comparison with other companies in the Medical Devices industry. Currently, HYPR has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items